-- D. Medical Gains Most in Week on U.S. Diabetes Guide Listing
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-01-04T10:56:41Z
-- http://www.bloomberg.com/news/2012-01-04/d-medical-gains-most-in-week-on-u-s-diabetes-guide-listing.html
D. Medical Industries Ltd. (DMED)  surged the
most in more than a week after the maker of drug delivery
devices said its infusion set has been listed in a U.S. diabetes
consumer guide.  The  shares (DMED)  rose 3.1 percent, the biggest intraday gain
since Dec. 25, to 5.30 shekels at 12:32 p.m. in Tel Aviv, giving
the Tirat Carmel, Israel-based company a market value of 43.3
million shekels ($11 million).  D. Medical  said  its Spring Universal Infusion Set for the
monitoring of insulin delivery has been listed in the American
Diabetes Association 2012 Consumer Guide, according to a filing
with the Tel Aviv Stock Exchange today.  To contact the reporter on this story:
Shoshanna Solomon in  Tel Aviv  at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  